retatrutide phase 3 Delivers 22.6% Weight Loss in TRIUMPH-2 and TRIUMPH-3 Trials | Kh Mahfuz Ullah posted on the topic Phase III trials confirm benefits

Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members

If prescribed, the patient can get the medication from a pharmacy

Skin around the eyes is significantly thinner than other facial areas, has minimal oil glands, and sits close to the sensitive eyeball

These people are not recommended by the FDA to take GLP-1 medications